BioAgilytix

BioAgilytix is a prominent bioanalytical contract research organization (CRO) based in the United States. With nearly 30 years of experience, the company specializes in high-quality bioanalytical testing services that support drug development, particularly for large molecule biologics. BioAgilytix operates advanced laboratories in key locations, including Durham, Boston, San Diego, Hamburg, Melbourne, and Brisbane, employing around 1,000 people and generating approximately $280.7 million in revenue. The company offers a wide range of bioanalytical services throughout the drug development lifecycle, including assay development, validation, sample analysis, and quality control. Core services encompass pharmacokinetics, immunogenicity assays, biomarker identification, and cell-based assays. BioAgilytix utilizes advanced testing platforms tailored to client needs and supports various sectors, including pharmaceuticals, biotechnology, and agricultural biotechnology. The company has established itself as a trusted partner for many leading global pharmaceutical and biotechnology firms, thanks to its scientific excellence and regulatory compliance.